new medicines

rare-1280x720

Major change for rare disease treatments on way, signals MHRA

A new paper from the MHRA sets out UK regulator's intention to overhaul its rulebook for rare disease therapies.

04 Nov 2025

eczema

Nemolizumab approved for prurigo nodularis and atopic dermatitis

Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.

18 Feb 2025

2018 pill_s.jpg

Key 2018 practice developments

This CPD module provides an overview of some of the major developments in pharmacy practice during 2018.

14 Dec 2018

2017 review_s.jpg

Key practice developments of 2017

This CPD module provides an overview of key practice developments of 2017.

13 Dec 2017

Change privacy settings